Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC.
J Clin Invest
; 132(23)2022 12 01.
Article
in En
| MEDLINE
| ID: mdl-36194476
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptors, Androgen
/
Prostatic Neoplasms, Castration-Resistant
Type of study:
Prognostic_studies
Limits:
Humans
/
Male
Language:
En
Journal:
J Clin Invest
Year:
2022
Document type:
Article